Skip to main content
. 2021 Mar 13;11(8):2362–2395. doi: 10.1016/j.apsb.2021.03.019

Figure 8.

Figure 8

Applications of MOFs in lung disease (A) Cholesterol modification of CD-MOF to improve aerodynamic properties for pulmonary delivery of budesonide. Reprinted with permission from Ref. 68. Copyright © 2019, Elsevier (B) INH-loaded MOF combined with PLGA and LC microparticle for pulmonary delivery of anti-tuberculosis drug. Reprinted with permission from Ref. 214. Copyright © 2019, MDPI(OA) (C) Graphical mechanism of nano-MOF-based particle lung retention after i.v. administration. Reprinted with permission from Ref. 195. Copyright © 2017, WILEY-VCH.